KMC Speciality Hospitals (India)
- Market Cap
- ₹3,323 Cr
- P/E
- 54.34
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 26.20%
- Debt to Equity
- 0.37
- EPS (TTM)
- ₹3.75
- Book Value
- ₹14.90
- Market Cap
- ₹3,323 Cr
- P/E (TTM)
- 54.34
- P/B
- 13.68
- ROE
- 24.90%
- Dividend Yield
- 0.00%
- EBITDA
- ₹93.00 Cr
- 52W High
- ₹210.25
- 52W Low
- ₹128.48
- Day Range
- ₹199.00 – ₹210.25
- Volume
- 13,95,170
Peer Comparison
Healthcare › Healthcare Services › Hospital
| 9,200.00 | 59.00 | 1,32,282 | 12.47 | 0.23% | 21.50% | 17.40% | 27,630 | 2,337 | |
| 1,081.00 | 76.23 | 1,05,215 | 9.28 | 0.20% | 14.70% | 14.70% | 9,146 | 1,380 | |
| 702.20 | 101.77 | 92,366 | 6.01 | 0.00% | 6.72% | 8.30% | 12,370 | 873 | |
| 779.30 | 110.70 | 67,929 | 8.72 | 0.41% | 11.30% | 11.60% | 6,508 | 564 | |
| 825.00 | 59.96 | 62,284 | 5.94 | 0.13% | 11.20% | 13.40% | 9,910 | 1,061 | |
| 1,480.20 | 64.33 | 39,798 | 9.20 | 0.03% | 15.20% | 17.40% | 5,053 | 613 | |
| 1,943.70 | 46.25 | 39,722 | 7.94 | 0.24% | 20.50% | 15.50% | 10,273 | 859 | |
| 203.78 | 54.34 | 3,323 | 13.68 | 0.00% | 24.90% | 26.20% | 349 | 62 | |
| Median 8 companies | 953.00 | 62.15 | 65,107 | 8.96 | 0.17% | 14.95% | 15.10% | 9,528 | 866 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 83
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 33
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 93
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 67
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 97
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 49
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has delivered good profit growth of 29.6% CAGR over last 5 years
- Company's median sales growth is 22.9% of last 10 years
Weaknesses
2- Stock is trading at 13.7 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 2 | 13 |
| Oscillators | Bearish | 4 | 2 | 3 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 74.55
- Bearish
- MACD (12,26,9)
- 11.08
- Bullish
- SMA (50)
- 161.15
- Bullish
- SMA (200)
- 119.85
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +21.68% |
|---|---|
| 5Y | +24.33% |
| 3Y | +25.18% |
| 1Y | +31.90% |
| TTM | +32.20% |
Net profit
| 10Y | +31.67% |
|---|---|
| 5Y | +29.31% |
| 3Y | +20.29% |
| 1Y | +123.81% |
| TTM | +93.75% |
Operating cash flow
| 10Y | +29.40% |
|---|---|
| 5Y | +24.89% |
| 3Y | +35.15% |
| 1Y | +36.21% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +10.16 pp |
|---|---|
| 5Y | +6.43 pp |
| 3Y | +1.84 pp |
| 1Y | +4.19 pp |
| TTM | +4.90 pp |
Revenue by year
| Mar 2017 | ₹55.00 Cr |
|---|---|
| Mar 2018 | ₹71.00 Cr |
| Mar 2019 | ₹82.00 Cr |
| Mar 2020 | ₹96.00 Cr |
| Mar 2021 | ₹103 Cr |
| Mar 2022 | ₹136 Cr |
| Mar 2023 | ₹156 Cr |
| Mar 2024 | ₹177 Cr |
| Mar 2025 | ₹232 Cr |
| Mar 2026 | ₹306 Cr |
Net profit by year
| Mar 2017 | ₹5.00 Cr |
|---|---|
| Mar 2018 | ₹7.00 Cr |
| Mar 2019 | ₹9.00 Cr |
| Mar 2020 | ₹12.00 Cr |
| Mar 2021 | ₹13.00 Cr |
| Mar 2022 | ₹24.00 Cr |
| Mar 2023 | ₹27.00 Cr |
| Mar 2024 | ₹30.00 Cr |
| Mar 2025 | ₹21.00 Cr |
| Mar 2026 | ₹47.00 Cr |
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 49 | 45 | 53 | 56 | 61 | 61 | 67 | 75 | 82 | 82 | 92 | 93 |
| Expenses | 31 | 35 | 33 | 40 | 44 | 45 | 46 | 50 | 54 | 57 | 56 | 63 | 65 |
| Operating Profit | 11 | 14 | 12 | 13 | 13 | 16 | 15 | 16 | 21 | 25 | 26 | 28 | 28 |
| OPM % | 26% | 29% | 26% | 24% | 22% | 26% | 25% | 25% | 28% | 30% | 31% | 31% | 30% |
| Other Income | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
| Interest | 0 | 0 | 0 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
| PBT | 9 | 12 | 9 | 7 | 5 | 10 | 9 | 10 | 15 | 18 | 20 | 22 | 22 |
| Tax % | 26% | 24% | 25% | 26% | 27% | 25% | 49% | 25% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 7 | 9 | 7 | 6 | 4 | 8 | 5 | 8 | 11 | 14 | 15 | 17 | 16 |
| EPS (₹) | 0.42 | 0.58 | 0.43 | 0.34 | 0.24 | 0.46 | 0.28 | 0.46 | 0.66 | 0.84 | 0.90 | 1.02 | 0.99 |
| YoY Sales growth | 7 | 23 | 9 | 30 | 33 | 25 | 36 | 25 | 33 | 34 | 35 | 38 | 24 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | 306 | 349 |
| Expenses | 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 174 | 217 | 242 |
| Operating Profit | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 | 88 | 107 |
| OPM % | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% | 29% | 31% |
| Other Income | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 5 | 6 |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 9 | 8 |
| Depreciation | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 | 22 | 23 |
| PBT | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 | 63 | 82 |
| Tax % | 0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% | 26% | — |
| Net Profit | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | 47 | 61 |
| EPS (₹) | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 | 2.87 | 3.75 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Sales growth | 14 | 17 | 29 | 29 | 16 | 17 | 7 | 33 | 14 | 14 | 31 | 32 | 32 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | −6 | −3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 | 194 | 227 |
| Borrowings | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | 84 | 89 |
| Other Liabilities | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | 38 | 47 |
| Total Liabilities | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 | 379 |
| Fixed Assets | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | 248 | 253 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | 0 | 0 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | 84 | 124 |
| Total Assets | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 | 379 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | 79 |
| Investing | −1 | −1 | −4 | −19 | −9 | −8 | −43 | −29 | −48 | −56 | −51 | −17 |
| Financing | −5 | −5 | −5 | 6 | −5 | −4 | 18 | −1 | 16 | 20 | −2 | −21 |
| Net Cash Flow | 0 | 0 | 1 | −1 | 1 | −1 | 1 | 0 | 0 | 3 | 4 | 41 |
| Free Cash Flow | 5 | 5 | 6 | −3 | 13 | 7 | −15 | 16 | −12 | −37 | −6 | 63 |
| CFO/EBITDA | 112 | 91 | 94 | 100 | 113 | 66 | 120 | 102 | 100 | 101 | 112 | 99 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 | 9 |
| Inventory Days | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 | 31 |
| Days Payable | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 113 | 153 | 82 |
| Cash Conversion Cycle | −115 | −112 | −94 | −107 | −125 | −48 | −68 | −53 | −56 | −73 | −105 | −42 |
| Working Capital Days | −70 | −60 | −46 | −37 | −28 | −18 | −15 | −27 | −22 | −73 | −22 | −19 |
| ROCE % | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% | 26% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view KMC Speciality Hospitals insights
63 extracted metrics across FY10–FY27.
Documents
- 12 Jun 2026
- 18 Mar 2026
- 24 Nov 2023
- 25 Oct 2023
- 18 Oct 2022
- Intimation 6 Nov 2026
- General announcements 8 Oct 2026
Frequently Asked Questions about KMC Speciality Hospitals (India)
What does KMC Speciality Hospitals (India) Ltd do?
Where is KMC Speciality Hospitals (India) Ltd (KMCSHIL) listed?
Which sector does KMC Speciality Hospitals (India) Ltd belong to?
What is the market capitalisation of KMC Speciality Hospitals (India) Ltd?
What is the PE ratio of KMC Speciality Hospitals (India) Ltd?
What is the 52-week high and low of KMC Speciality Hospitals (India) Ltd?
What is the Return on Equity (ROE) of KMC Speciality Hospitals (India) Ltd?
Company Information
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524520.md for KMC Speciality Hospitals (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.